What Is GHRP-6? Benefits, Research & Safety

GHRP-6 was developed in the 1980s through the work of Cyril Bowers and colleagues, who pioneered the discovery of growth hormone-releasing peptides. The research began with observations that certain synthetic peptides could stimulate GH release independently of the natural GHRH pathway. GHRP-6 emerged from systematic structure-activity relationship studies aimed at identifying potent GH secretagogues. It was designated as the sixth peptide in a series of related compounds, hence the name. The peptide was extensively studied in the late 1980s and 1990s, with clinical trials evaluating its potential for treating GH deficiency and other conditions. These studies confirmed its GH-releasing efficacy but also highlighted its appetite-stimulating effects. The discovery of ghrelin in 1999 and the cloning of its receptor (which turned out to be the target of GHRPs) provided important context for understanding GHRP-6's mechanism of action. GHRPs were effectively synthetic ghrelin mimetics developed before ghrelin itself was discovered. Despite extensive research, GHRP-6 has not achieved regulatory approval for therapeutic use. It remains available as a research compound.